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Clinical Observations
Effects of Chinese Herbal Medicine Combined with He-Ne Laser on 
Lipoperoxide and Superoxide Dismutase in Chloasma Patients 
WU Yan-hua ਈ㡇ढ, LI Qi-lin ᴢ݊ᵫ & YANG Xiu-wen ᴼ⾔᭛
Departments of Chinese Medicine and Dermatology, Guangzhou Red Cross Hospital, Guangzhou 510220, China
Objective: To observe the effects of Chinese decoction and ligustrazin hydrochloride injection combined 
with He-Ne laser on lipoperoxide (LPO) and Superoxide dismutase (SOD) in patients with chloasma. 
Methods: 90 cases of chloasma were randomly divided into the following two groups: a treatment group (of 
54 cases) treated by a self-prepared prescription for toning the kidneys and relieving the depressed liver to 
remove blood stasis, ligustrazin hydrochloricde injection and He-Ne laser therapy, and a control group (of 36 
cases) treated with oral administration of Vitamin E and Vitamin C plus external application of 20% Azelaic 
acid cream. Results: The total effective rate in the treatment group was 79.6%, which was significantly 
higher than that of the control group (P<0.05). After treatment, the LPO level in the treatment group was 
significantly lowered (P<0.01), and the SOD level was significantly elevated (P<0.05). Conclusion: The 
therapeutic methods adopted in the treatment group may show the action of antioxidation, providing good 
clinical effects for treating chloasma. 
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Chloasma is a common skin disease characterized by 
pigmentation on the face with the cause unknown. 
Recent studies have shown that it is related with the 
change of oxygen free radicals (OFR), in order to 
explore the roles of lipoperoxide (LPO) and 
Superoxide dismutase (SOD) in morbidity of 
chloasma and try to find better therapy to treat the 
disease, the authors used Chinese herbal medicine 
combined with He-Ne laser therapy to observe the 
effects on LPO and SOD in patients with chloasma. A 
report follows.   
CLINICAL MATERIALS 
All 90 cases in this series were females from the 
Departments of TCM and Dermatology, Guangzhou 
Red Cross Hospital. They all met the criteria for 
diagnosis of chloasma.1 Patients who had taken 
medicines affecting endocrine functions in the past 
half a year, those experiencing menopause, pregnancy, 
diabetes, chronic dysfunction of the liver and kidney, 
autoimmune diseases, and those who had been 
treated by other therapies in the past one month were 
excluded. By drawing lots, the patients were 
randomly divided into two groups. In the treatment 
group of 54 cases, the age range was from 19 to 50 
years (mean 38.5 years) with the illness course from 
2 months to 10 years (mean 5.4 years). In the control 
group of 36 cases, the age range was from 20 to 49 
years (mean 37.6 years) with the illness course from 
3 months to 10 years (mean 5.2 years). There were no 
significant differences in age and course of disease 
between the two groups. LPO and SOD levels of the 
peripheral blood were detected before and after 
treatment in the treatment group. In addition, thirty 
healthy subjects were taken as the normal controls for 
comparison of the LPO and SOD levels. The age 
range was from 18 to 50 years (mean 36.4 years). 
METHODS 
Chinese herbal medicine combined with He-Ne laser 
therapy were given in the treatment group. The herbal 
prescription was composed of Zhen Zhu Mu (⦡⦴↡
Concha Margaritifera Usta) 30g (decocted first), Nü 
Zhen Zi (ཇ䋲ᄤ Fructus Ligustri Lucidi) 20g, Tu Si 
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Zi (㦳ϱᄤ Semen Cuscutae) 20g, Shan Zhu Yu (ቅ
㤅㨌 Fructus Corni) 15g, Sang Shen (ḥἍ Fructus 
Mori) 15g, Yu Jin (䚕䞥 Radix Curcumae) 15g, Fu 
Ling (㤃㢧 Poria) 15g, Su Xin Hua (㋴佼㢅 jasmine 
flower) 15g, Dang Gui (ᔧᔦ  Radix Angelicae 
Sinensis) 10g, Chai Hu (᷈㚵 Radix bupleuri) 10g, 
Bai Zhi (ⱑ㢋 Radix Angelicae Dahuricae) 10g, and 
Hong Hua (㑶㢅 Flos Carthami) 5g. The prescription 
should be modified according to individual condition 
of the patients. The decoction was taken one dose 
daily for 4 weeks as one therapeutic course. The 
He-Ne laser was used for intravascular irradiation, 
with a needle inserted into the median cubital vein 
and connected with optical fibers through the venous 
catheter. The irradiation of 1.5 mW was given 30 min 
each time, once daily. Following each irradiation, 
10% 500 ml glucose added with 240 mg ligustrazin 
hydrochloride injection was intravenously dripped. 
One-week of treatments made up a therapeutic course 
with a 3-week interval between courses.  
In the control group, Vitamin E in a dose of 50 mg 
and Vitamin C in a dose of 200 mg were orally 
administered three times daily, with 20% Azelaic acid 
cream externally applied twice daily on the skin 
lesions of the face, one-month treatment constituting 
a therapeutic course.  
Two courses of treatments were given for both  
groups. During the course of treatment, the patients 
were examined once a week, and the change in the 
skin lesions was recorded. The therapeutic effects 
were evaluated after two courses of treatment. LPO 
and SOD levels of the peripheral blood were detected 
before and after two courses of treatment respectively 
by thio-barbituric acid chromatometry and pyrogallic 
acid autoxidation. 
Statistical Analysis 
SAS10.0 software was used for statistical analysis. 
The Ȥ2 test was used for evaluation of the therapeutic 
effect for chloasma, the rank-sum test for comparison 
of LPO and SOD between the treatment group and 
normal control group, and the paired rank-sum test 
for intergroup comparison of LPO and SOD in the 
treatment group before and after treatment.    
Criteria for Therapeutic Effects 1
Basically cured: The chloasma area was reduced by 
90% with basic disappearance of the color 
determined with the naked eye. Markedly relieved: 
the chloasma area was reduced by 60% but <90% 
with obvious fading of the color determined with the 
naked eye. Improved: reduction of the chloasma area 
by 30% but <60% with fading of the color 
determined with the naked eye. Failed: reduction of 
the chloasma area by <30% with no obvious change 
of the color determined with the naked eye. 
RESULTS 
Of the 54 cases treated in the treatment group, 17 
cases were basically cured, 26 cases markedly 
relieved, 10 cases improved and 1 case failed, with a 
total effective rate of 79.6%. Of the 36 cases treated 
in the control group, 5 cases were basically cured, 15 
cases markedly relieved, 12 cases improved and 4 
cases failed, with a total effective rate of 55.6%. The 
therapeutic effect in the treatment group was 
significantly better than that of the control group 
(P<0.05). 
Comparison of the LPO and SOD Levels Before 
and After Treatment 
It can be seen from Table 1 that before treatment 
there are significant differences in the LPO and SOD 
levels between the treatment group and the normal 
control group, showing an obvious increase of LPO 
(P<0.01) and a marked decrease of SOD (P<0.01). 
This indicates the imbalance between oxidation and 
antioxidation, leading to generation or aggravation of 
chloasma.  
After treatment, the LPO and SOD levels were 
detected only in 34 of 54 cases in the treatment group. 
As shown in Table 2, after treatment the LPO level is 
markedly lowered (P<0.01) and the SOD level is 
significantly elevated (P<0.05), indicating an 
improvement in the imbalance between oxidation and 
antioxidation with removal or alleviation of 
chloasma. 
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Table 1. The LPO and SOD Levels before Treatment 
in the Treatment Group and the Normal Control 
Group 
Group Cases LPO (ȝmol/L) SOD (IU/ml)
Treatment 54 5.42±3.87** 29.36±5.11**
Normal Control 30 3.27±2.68 33.81±6.43 
Note: **P<0.01, compared with normal control group 
Table 2. Comparison of the LPO and SOD Levels 
Before and After Treatment in the Treatment Group 
Group Cases LPO (mol/L) SOD (IU/ml) 
Pretreat. 34 6.37±4.30 29.55±6.01 
Postreat. 34  3.73±2.90** 33.49±9.06* 
Note: *P<0.05 and **P<0.01 for the intragroup comparison in 
the treatment group. 
Adverse Effects 
No obvious side effects were found in the treatment 
group. 
DISCUSSION 
Chloasma is a facial skin disease related to a disorder 
of the pigment metabolism, and it often occurs in 
women. Generally, it is thought to be related to 
ultraviolet irradiation, endocrine disorder and genetic 
factors. Recent studies have shown that its generation 
is related to OFR changes.2 Under normal conditions, 
there are many kinds of antioxidase in the human 
body, such as SOD and catalase (CAT), which can 
effectively eliminate the oxidation-induced lesion and 
keep a dynamic equilibrium between oxidation and 
anti-oxidation. In patients with chloasma, the 
equilibrium is broken, the physiologically generated 
oxidative products like peroxidized lipid cannot be 
effectively removed, resulting in accumulation of 
LPO. The present study shows that in patients with 
chloasma the LPO level is obviously higher and the 
SOD level obviously lower than that of normal 
subjects. Elevation of LPO can accelerate the 
oxidizing reaction of tyrosine series and increase the 
melanin produced by melanin cells. Meanwhile, due 
to instability of LPO, the degeneration product, 
malonaldehyde, can make protein molecules cross- 
linkied to form fluorescence chromophore 
represented by pigment.3 TCM holds that chloasma 
results from blood stasis, and it is related to 
deficiency of the kidneys, depression of the liver, and 
disorder of qi and blood.4
Chinese herbal medicine combined with He-Ne laser 
therapy is a new method for treating chloasma. The 
herbal prescription for oral administration functions 
to tone the kidneys, relieve the depressed liver, and 
regulate the circulation of qi and blood. According to 
modern pharmacological studies, Shan Zhu Yu (ቅ㤅
㨌 Fructus Corni), Nü Zhen Zi (ཇ䋲ᄤ Fructus 
Ligustri Lucidi), Sang Shen (ḥἍ Fructus Mori), Tu 
Si Zi (㦳ϱᄤ Semen Cuscutae), Dang Gui (ᔧᔦ
Radix Angelicae Sinensis) and Yu Jin (䚕䞥 Radix 
Curcumae) have the ability to elevate the activities of 
SOD, removing oxygen free radicals, defending 
against lipid peroxidation, lowering blood viscosity, 
dilating blood vessels, and improving blood flow.4,5
Ligustrazin hydrochloride extracted from Rhizoma 
Ligustici is a kind of alkaloid, which can be used to 
remove blood stasis to promote blood circulation, 
improve microcirculation, lower whole blood 
viscosity, protect or enhance SOD activities, 
eliminate the oxygen free radicals, anti-lipid 
peroxidation, and inhibit the proliferation of 
melanocytes, the synthesis of melanocytes and the 
tyrosinese activities.6,7 A low intensity of He-Ne laser 
for intravascular irradiation can strengthen the 
activities of SOD and catalase, enhance the plasma 
copper- protein and endogenous Vitamin K levels, 
defend against lipid peroxidation, remove oxygen 
free radicals, improve blood viscosity, micro- 
circulation and hypoxia, and correct abnormal lipid 
metabolism.8 Therefore, after treatment the LPO level 
was obviously lowered, the SOD level markedly 
elevated, and the imbalance between oxidation and 
anti-oxidation regained, thus showing therapeutic 
effects for chloasma.  
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